LU86484A1 - Sels de furosemide - Google Patents

Sels de furosemide Download PDF

Info

Publication number
LU86484A1
LU86484A1 LU86484A LU86484A LU86484A1 LU 86484 A1 LU86484 A1 LU 86484A1 LU 86484 A LU86484 A LU 86484A LU 86484 A LU86484 A LU 86484A LU 86484 A1 LU86484 A1 LU 86484A1
Authority
LU
Luxembourg
Prior art keywords
furosemide
quaternary ammonium
choline
tetra
arylammonium
Prior art date
Application number
LU86484A
Other languages
English (en)
French (fr)
Inventor
Lester Chafetz
Jose Philip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of LU86484A1 publication Critical patent/LU86484A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
LU86484A 1985-07-02 1986-06-20 Sels de furosemide LU86484A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof
US75176385 1985-07-02

Publications (1)

Publication Number Publication Date
LU86484A1 true LU86484A1 (fr) 1986-12-02

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86484A LU86484A1 (fr) 1985-07-02 1986-06-20 Sels de furosemide

Country Status (14)

Country Link
US (1) US4663348A (cg-RX-API-DMAC7.html)
JP (1) JPS625975A (cg-RX-API-DMAC7.html)
AU (1) AU599034B2 (cg-RX-API-DMAC7.html)
BE (1) BE904986A (cg-RX-API-DMAC7.html)
CH (1) CH670448A5 (cg-RX-API-DMAC7.html)
DE (1) DE3619665A1 (cg-RX-API-DMAC7.html)
DK (1) DK312586A (cg-RX-API-DMAC7.html)
FR (1) FR2584405B1 (cg-RX-API-DMAC7.html)
GB (1) GB2189239B (cg-RX-API-DMAC7.html)
IT (1) IT1191972B (cg-RX-API-DMAC7.html)
LU (1) LU86484A1 (cg-RX-API-DMAC7.html)
NL (1) NL8601519A (cg-RX-API-DMAC7.html)
SE (1) SE8602917L (cg-RX-API-DMAC7.html)
ZA (1) ZA864207B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
US5330280A (en) * 1991-12-03 1994-07-19 Kokuyo Kabushiki Kaisha Filing apparatus of both-side opening/closing type
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2416404C1 (ru) * 2009-10-05 2011-04-20 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Средство, обладающее мочегонным действием
BR112012020110B1 (pt) 2010-02-10 2021-06-08 Kissei Pharmaceutical Co., Ltd. composto derivado heterocíclico fusionado, composição farmacêutica que compreende o mesmo e uso terapêutico do dito composto
CN105431145B (zh) 2013-04-05 2019-12-10 Sc医药品有限公司 用于呋塞米的皮下施用的药物制剂
WO2020120482A1 (en) 2018-12-10 2020-06-18 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
EP3906020B1 (en) 2019-01-04 2025-12-31 SQ Innovation AG Pharmaceutical compositions of torsemide and their uses
CN113271923B (zh) 2019-01-04 2025-05-13 Sq创新股份公司 呋塞米的药物组合物及其用途
CA3128033A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (cg-RX-API-DMAC7.html) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
FR2584405A1 (fr) 1987-01-09
DK312586D0 (da) 1986-07-01
IT8648183A0 (it) 1986-06-25
BE904986A (fr) 1986-12-24
DK312586A (da) 1987-01-03
GB2189239A (en) 1987-10-21
DE3619665A1 (de) 1987-01-08
AU5889086A (en) 1987-01-08
CH670448A5 (cg-RX-API-DMAC7.html) 1989-06-15
SE8602917D0 (sv) 1986-07-01
GB8615275D0 (en) 1986-07-30
GB2189239B (en) 1989-02-01
AU599034B2 (en) 1990-07-12
NL8601519A (nl) 1987-02-02
ZA864207B (en) 1987-02-25
US4663348A (en) 1987-05-05
IT8648183A1 (it) 1987-12-25
JPS625975A (ja) 1987-01-12
FR2584405B1 (fr) 1989-02-24
SE8602917L (sv) 1987-01-03
IT1191972B (it) 1988-03-31

Similar Documents

Publication Publication Date Title
CA1203242A (fr) Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
EP0233106B1 (fr) (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique
LU86484A1 (fr) Sels de furosemide
EP0233853B1 (fr) Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
CH668594A5 (fr) Preparations parenterales de phenytoine.
CA1242458A (fr) Ethers-oxydes et ethers-oximes d'alcoylaminoalcools comme medicaments, produits nouveaux et procedes pour leur preparation
LU86403A1 (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers
EP0092287B2 (fr) Sels d'acétylcystéine, leur préparation et leur utilisation
CA2064999A1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et utilisation comme medicaments
FR2620450A1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
EP0356325B1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique
EP0737508A1 (fr) Utilisation d'un composé hydrofluorocarboné dans une émulsion, émulsion et composition comprenant un tel composé
MC1485A1 (fr) Procede de preparation de solutions aqueuses de sulfonamides potentialises
EP0209511B1 (fr) Chlorhydrates de chlorures de dérivés d'aminoalkyl-2 hydroxy-9 ellipticinium et compositions pharmaceutiques en contenant
KR850000210B1 (ko) 옥사졸린의 제조방법
FR2594439A1 (fr) Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique
JPH0144172B2 (cg-RX-API-DMAC7.html)
BE1001262A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
EP0729749B1 (fr) Compositions pharmaceutiques comprenant des dérivés de dinoréburnaménine
CH622023A5 (en) Process for the preparation of a water-soluble compound based on a substituted phenylaminoalcohol
BE1001263A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
MC1425A1 (fr) Nouvelles prostaglandines
LU83081A1 (fr) Compositions antitumeurs